301175-64-4Relevant academic research and scientific papers
Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors
Pan, Ting,Ding, Yanchao,Wu, Liyang,Liang, Liting,He, Xin,Li, Qianwen,Bai, Chuan,Zhang, Hui
, p. 480 - 501 (2019)
The capsid assembly is an essential step for Hepatitis B Virus (HBV) life cycle and is an important target for anti-HBV drug development. In this report, we identified a hit compound with aminothiazole structure by the high throughput screening (HTS) which inhibited the interaction of HBV capsid protein within the cells. The structure hopping and SAR studies of the hit compound afforded compound 79 with potent anti-HBV replication activity and good basic drug-like properties. The working mechanism studies showed that compound 79 could bind to the similar binding site of known HBV capsid inhibitor with heteroaryldihydropyrimidine (HAP) scaffold, through similar hydrophobic interactions but with a different hydrogen bond. This compound exerted potent inhibitory effect upon HBV production, either in cell culture or in mice with no obvious acute toxicity. We propose that further development of this compound could lead to novel potent anti-HBV inhibitors that target HBV capsid assembly.
